Corrigendum to “Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity” [Toxicol. Appl. Pharmacol. 321 (2017) 1–17] (S0041008X17300649) (10.1016/j.taap.2017.02.006));Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity

Toxicology and Applied Pharmacology

Volumn 321, Issue , 2017, Pages 1-17

  Fader, Kelly A ^a,b   Nault, Rance ^a,b   Kirby, Mathew P ^a   Markous, Gena ^a   Matthews, Jason ^c   Zacharewski, Timothy R ^a,b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Heme; Hepcidin; Iron; NAFLD; REV ERB ; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 5 AMINOLEVULINATE SYNTHASE; AROMATIC HYDROCARBON RECEPTOR; HEME; HEPCIDIN; IRON; NUCLEAR RECEPTOR NR1D1; RNA; SESAME SEED OIL; TRANSFERRIN; UROPORPHYRINOGEN DECARBOXYLASE; CELL RECEPTOR; NR1D1 PROTEIN, MOUSE; NR1D2 PROTEIN, MOUSE; POLLUTANT; POLYCHLORINATED DIBENZODIOXIN; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY ELECTROPHORESIS; CLINICAL CHEMISTRY; CONTROLLED STUDY; DUODENUM EPITHELIUM; HEPCIDIN DEFICIENCY; HOMEOSTASIS; IRON OVERLOAD; IRON URINE LEVEL; LIVER TOXICITY; MALE; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEFICIENCY; RNA SEQUENCE; TRANSFERRIN BLOOD LEVEL; ANIMAL; C57BL MOUSE; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENETICS; LIVER; METABOLISM; PATHOLOGY; POLLUTANT; TOXICITY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FEMALE; HEME; HEPCIDINS; IRON OVERLOAD; LIVER; MALE; MICE; MICE, INBRED C57BL; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; POLYCHLORINATED DIBENZODIOXINS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS;

EID: 85013816220     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2018.03.001     Document Type: Erratum

References (68)

1. Aigner, E., Weiss, G., Datz, C., Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World J. Hepatol. 7:2 (2015), 177–188.
2. Al-Bayati, Z.A., Stohs, S.J., The role of iron in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced lipid peroxidation by rat liver microsomes. Toxicol. Lett. 38:1–2 (1987), 115–121.
3. Al-Turk, W.A., Shara, M.A., Mohammadpour, H., Stohs, S.J., Dietary iron and 2,3,7,8-tetrachlorodibenzo-p-dioxin induced alterations in hepatic lipid peroxidation, glutathione content and body weight. Drug Chem. Toxicol. 11:1 (1988), 55–70.
4. Birnbaum, L.S., McDonald, M.M., Blair, P.C., Clark, A.M., Harris, M.W., Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah locus. Fundam. Appl. Toxicol. 15:1 (1990), 186–200.
5. Boverhof, D.R., Burgoon, L.D., Tashiro, C., Chittim, B., Harkema, J.R., Jump, D.B., Zacharewski, T.R., Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-mediated hepatotoxicity. Toxicol. Sci. 85:2 (2005), 1048–1063.
6. Brasse-Lagnel, C., Karim, Z., Letteron, P., Bekri, S., Bado, A., Beaumont, C., Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology 140:4 (2011), 1261–1271 (e1261).
7. Casals-Casas, C., Desvergne, B., Endocrine disruptors: from endocrine to metabolic disruption. Annu. Rev. Physiol. 73 (2011), 135–162.
8. Chiabrando, D., Vinchi, F., Fiorito, V., Mercurio, S., Tolosano, E., Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front. Pharmacol., 5, 2014, 61.
9. D'Alessio, F., Hentze, M.W., Muckenthaler, M.U., The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. J. Hepatol. 57:5 (2012), 1052–1060.
10. Denison, M.S., Soshilov, A.A., He, G., DeGroot, D.E., Zhao, B., Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 124:1 (2011), 1–22.
11. Eckel, J.E., Gennings, C., Chinchilli, V.M., Burgoon, L.D., Zacharewski, T.R., Empirical bayes gene screening tool for time-course or dose-response microarray data. J. Biopharm. Stat. 14:3 (2004), 647–670.
12. Eckel, J.E., Gennings, C., Therneau, T.M., Burgoon, L.D., Boverhof, D.R., Zacharewski, T.R., Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics 21:7 (2005), 1078–1083.
13. Fader, K.A., Nault, R., Ammendolia, D.A., Harkema, J.R., Williams, K.J., Crawford, R.B., Kaminski, N.E., Potter, D., Sharratt, B., Zacharewski, T.R., 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters lipid metabolism and depletes immune cell populations in the jejunum of C57BL/6 mice. Toxicol. Sci. 148:2 (2015), 567–580.
14. Fader, K.A., Nault, R., Zhang, C., Zacharewski, T.R., Aryl hydrocarbon receptor-elicited effects on bile acid homeostasis: Alterations in biosynthesis, enterohepatic circulation, and microbial metabolism. Scientific Reports, 2017 (Submitted for publication).
15. Fargion, S., Mattioli, M., Fracanzani, A.L., Sampietro, M., Tavazzi, D., Fociani, P., Taioli, E., Valenti, L., Fiorelli, G., Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am. J. Gastroenterol. 96:8 (2001), 2448–2455.
16. Feng, D., Liu, T., Sun, Z., Bugge, A., Mullican, S.E., Alenghat, T., Liu, X.S., Lazar, M.A., A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331:6022 (2011), 1315–1319.
17. Fleming, R.E., Holden, C.C., Tomatsu, S., Waheed, A., Brunt, E.M., Britton, R.S., Bacon, B.R., Roopenian, D.C., Sly, W.S., Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 98:5 (2001), 2707–2711.
18. Ford, E.S., Li, C., Zhao, G., Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J. Diabetes 2:3 (2010), 180–193.
19. Gasiewicz, T.A., Geiger, L.E., Rucci, G., Neal, R.A., Distribution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J, DBA/2J, and B6D2F1/J mice. Drug Metab. Dispos. 11:5 (1983), 397–403.
20. George, D.K., Goldwurm, S., MacDonald, G.A., Cowley, L.L., Walker, N.I., Ward, P.J., Jazwinska, E.C., Powell, L.W., Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:2 (1998), 311–318.
21. Goldstein, J.A., Hickman, P., Bergman, H., Vos, J.G., Hepatic porphyria induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse. Res. Commun. Chem. Pathol. Pharmacol. 6:3 (1973), 919–928.
22. Gruger, E.H. Jr., Tappel, A.L., Reactions of biological antioxidants. I. Fe(3)-catalyzed reactions of lipid hydroperoxides with alpha-tocopherol. Lipids 5:3 (1970), 326–331.
23. Hankinson, O., The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35 (1995), 307–340.
24. Huang, G., Elferink, C.J., A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression. Mol. Pharmacol. 81:3 (2012), 338–347.
25. Ilyin, G., Courselaud, B., Troadec, M.B., Pigeon, C., Alizadeh, M., Leroyer, P., Brissot, P., Loreal, O., Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload. FEBS Lett. 542:1–3 (2003), 22–26.
26. Isom, H.C., McDevitt, E.I., Moon, M.S., Elevated hepatic iron: a confounding factor in chronic hepatitis C. Biochim. Biophys. Acta 1790:7 (2009), 650–662.
27. Jones, G., Greig, J.B., Pathological-changes in liver of mice given 2,3,7,8-tetrachlorodibenzo-P-dioxin. Experientia 31:11 (1975), 1315–1317.
28. Kang, H.S., Angers, M., Beak, J.Y., Wu, X., Gimble, J.M., Wada, T., Xie, W., Collins, J.B., Grissom, S.F., Jetten, A.M., Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol. Genomics 31:2 (2007), 281–294.
29. Kew, M.C., Hepatic iron overload and hepatocellular carcinoma. Liver Cancer 3:1 (2014), 31–40.
30. Kopec, A.K., Burgoon, L.D., Ibrahim-Aibo, D., Burg, A.R., Lee, A.W., Tashiro, C., Potter, D., Sharratt, B., Harkema, J.R., Rowlands, J.C., et al. Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice. Toxicol. Sci. 118:1 (2010), 286–297.
31. Kopec, A.K., Burgoon, L.D., Ibrahim-Aibo, D., Mets, B.D., Tashiro, C., Potter, D., Sharratt, B., Harkema, J.R., Zacharewski, T.R., PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: comparative toxicogenomic effects of dioxin and non-dioxin-like ligands. Toxicol. Appl. Pharmacol. 243:3 (2010), 359–371.
32. Kowdley, K.V., Trainer, T.D., Saltzman, J.R., Pedrosa, M., Krawitt, E.L., Knox, T.A., Susskind, K., Pratt, D., Bonkovsky, H.L., Grace, N.D., et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology 113:4 (1997), 1270–1277.
33. Kumar, S., Bandyopadhyay, U., Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157:3 (2005), 175–188.
34. Lamia, K.A., Storch, K.F., Weitz, C.J., Physiological significance of a peripheral tissue circadian clock. Proc. Natl. Acad. Sci. U. S. A. 105:39 (2008), 15172–15177.
35. Lesbordes-Brion, J.C., Viatte, L., Bennoun, M., Lou, D.Q., Ramey, G., Houbron, C., Hamard, G., Kahn, A., Vaulont, S., Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108:4 (2006), 1402–1405.
36. Li, M.D., Li, C.M., Wang, Z., The role of circadian clocks in metabolic disease. Yale J. Biol. Med. 85:3 (2012), 387–401.
37. Lou, D.Q., Nicolas, G., Lesbordes, J.C., Viatte, L., Grimber, G., Szajnert, M.F., Kahn, A., Vaulont, S., Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 103:7 (2004), 2816–2821.
38. Manis, J., Kim, G., Stimulation of iron absorption by polychlorinated aromatic hydrocarbons. Am. J. Phys. 236:6 (1979), E763–E768.
39. Mazur, A., Baez, S., Shorr, E., The mechanism of iron release from ferritin as related to its biological properties. J. Biol. Chem. 213:1 (1955), 147–160.
40. McConnell, E.E., Moore, J.A., Haseman, J.K., Harris, M.W., The comparative toxicity of chlorinated dibenzo-p-dioxins in mice and guinea pigs. Toxicol. Appl. Pharmacol. 44:2 (1978), 335–356.
41. Nault, R., Fader, K.A., Zacharewski, T., RNA-Seq versus oligonucleotide array assessment of dose-dependent TCDD-elicited hepatic gene expression in mice. BMC Genomics, 16(1), 2015, 373.
42. Nault, R., Fader, K.A., Ammendolia, D.A., Dornbos, P., Potter, D., Sharratt, B., Kumagai, K., Harkema, J.R., Lunt, S.Y., Matthews, J., et al. Dose-dependent metabolic reprogramming and differential gene expression in TCDD-elicited hepatic fibrosis. Toxicol. Sci. 154:2 (2016), 253–266.
43. Nault, R., Fader, K.A., Kirby, M.P., Ahmed, S., Matthews, J., Jones, A.D., Lunt, S.Y., Zacharewski, T.R., Pyruvate kinase isoform switching and hepatic metabolic reprogramming by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 149:2 (2016), 358–371.
44. Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., Vaulont, S., Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. U. S. A. 99:7 (2002), 4596–4601.
45. Parkash, O., Akram, M., Hereditary hemochromatosis. J. Coll. Physicians Surg. Pak. 25:9 (2015), 644–647.
46. Pierre, S., Chevallier, A., Teixeira-Clerc, F., Ambolet-Camoit, A., Bui, L.C., Bats, A.S., Fournet, J.C., Fernandez-Salguero, P., Aggerbeck, M., Lotersztajn, S., et al. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. Toxicol. Sci. 137:1 (2014), 114–124.
47. Qian, Y., Zhang, S., Guo, W., Ma, J., Chen, Y., Wang, L., Zhao, M., Liu, S., Polychlorinated biphenyls (PCBs) inhibit hepcidin expression through an estrogen-like effect associated with disordered systemic iron homeostasis. Chem. Res. Toxicol. 28:4 (2015), 629–640.
48. Raghuram, S., Stayrook, K.R., Huang, P., Rogers, P.M., Nosie, A.K., McClure, D.B., Burris, L.L., Khorasanizadeh, S., Burris, T.P., Rastinejad, F., Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat. Struct. Mol. Biol. 14:12 (2007), 1207–1213.
49. Roetto, A., Camaschella, C., New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis. Best Pract. Res. Clin. Haematol. 18:2 (2005), 235–250.
50. Rowley, B., Sweeney, G.D., Release of ferrous iron from ferritin by liver microsomes: a possible role in the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Can J. Biochem. Cell Biol. 62:12 (1984), 1293–1300.
51. Sinal, C.J., Bend, J.R., Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol. Pharmacol. 52:4 (1997), 590–599.
52. Slezak, B.P., Hatch, G.E., DeVito, M.J., Diliberto, J.J., Slade, R., Crissman, K., Hassoun, E., Birnbaum, L.S., Oxidative stress in female B6C3F1 mice following acute and subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 54:2 (2000), 390–398.
53. Smith, A.G., Clothier, B., Robinson, S., Scullion, M.J., Carthew, P., Edwards, R., Luo, J., Lim, C.K., Toledano, M., Interaction between iron metabolism and 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: a hepatic oxidative mechanism. Mol. Pharmacol. 53:1 (1998), 52–61.
54. Smith, A.G., Clothier, B., Carthew, P., Childs, N.L., Sinclair, P.R., Nebert, D.W., Dalton, T.P., Protection of the Cyp1a2(−/−) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 173:2 (2001), 89–98.
55. Sorg, O., Zennegg, M., Schmid, P., Fedosyuk, R., Valikhnovskyi, R., Gaide, O., Kniazevych, V., Saurat, J.H., 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites. Lancet 374:9696 (2009), 1179–1185.
56. Stohs, S.J., Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Free Radic. Biol. Med. 9:1 (1990), 79–90.
57. Sun, J., Hoshino, H., Takaku, K., Nakajima, O., Muto, A., Suzuki, H., Tashiro, S., Takahashi, S., Shibahara, S., Alam, J., et al. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 21:19 (2002), 5216–5224.
58. Sweeny, G.D., Jones, K.G., Cole, F.M., Basford, D., Krestynski, F., Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Science 204:4390 (1979), 332–335.
59. Trauner, M., Arrese, M., Wagner, M., Fatty liver and lipotoxicity. Biochim. Biophys. Acta 1801:3 (2010), 299–310.
60. Turek, F.W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., McDearmon, E., Laposky, A., Losee-Olson, S., Easton, A., Jensen, D.R., et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science 308:5724 (2005), 1043–1045.
61. Vos, J.G., Penninks, A.H., Dioxin and organotin compounds as model immunotoxic chemicals. De Matteis, F., Lock, E.A., (eds.) Selectivity and Molecular Mechanisms of Toxicity, 1987, 85–102 Palgrave Macmillan UK.
62. Vos, J.G., Moore, J.A., Zinkl, J.G., Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57B1/6 mice. Toxicol. Appl. Pharmacol. 29:2 (1974), 229–241.
63. Wang, C., Xu, C.X., Krager, S.L., Bottum, K.M., Liao, D.F., Tischkau, S.A., Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-alpha pathway activity in mice. Environ. Health Perspect. 119:12 (2011), 1739–1744.
64. Wolfe, W.H., Michalek, J.E., Miner, J.C., Pirkle, J.L., Caudill, S.P., Patterson, D.G. Jr., Needham, L.L., Determinants of TCDD half-life in veterans of operation ranch hand. J. Toxicol. Environ. Health 41:4 (1994), 481–488.
65. Wolff, F., Gulbis, B., Cotton, F., Spectrophotometric quantification of total urinary porphyrins as a screening test for porphyrias: threshold value revisited. Clin. Biochem. 46:18 (2013), 1825–1829.
66. Yang, J., Liao, M., Shou, M., Jamei, M., Yeo, K.R., Tucker, G.T., Rostami-Hodjegan, A., Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions. Curr. Drug Metab. 9:5 (2008), 384–394.
67. Zhao, N., Zhang, A.S., Enns, C.A., Iron regulation by hepcidin. J. Clin. Invest. 123:6 (2013), 2337–2343.
68. Zhao, N., Maxson, J.E., Zhang, R.H., Wahedi, M., Enns, C.A., Zhang, A.S., Neogenin facilitates the induction of hepcidin expression by hemojuvelin in the liver. J. Biol. Chem. 291:23 (2016), 12322–12325.